Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Resilient Biotics logo — Harnessing the power of the respiratory microbiome

Resilient Biotics

Harnessing the power of the respiratory microbiome

Founded 2016 United States Durham, United States 13 employees Series A Total: $7.17M Analytics, Biotechnology +1

General Information

Company Name Resilient Biotics
Founded Year 2016
Location United States Durham, United States +1
Employees 13
Industries Analytics, Biotechnology, Health and Wellness
Funding Stage Series A
Social

Get notified when Resilient Biotics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Resilient Biotics

Resilient Biotics is a biotechnology startup founded in 2016 with the slogan "Harnessing the power of the respiratory microbiome." The company is focused on developing non-antibiotic, microbiome-based therapeutics to combat complex respiratory infections in both human and animal health. This is achieved through a proprietary discovery platform that integrates high resolution genomic analyses, in-house machine learning algorithms, and targeted in vitro assays. Resilient Biotics has made significant strides in identifying microbiome-derived strains with immune activation and pathogen inhibition properties in respiratory tissues. The company boasts a broad pipeline of actives addressing both viral and bacterial infectious diseases, with positive in vivo efficacy data across multiple species. The United States-based startup recently garnered a noteworthy $7.17M Series A investment on 29 January 2021, attracting support from prominent investors including Berkeley Catalyst Fund, Fulcrum Global Capital, Viking Global Investors, and Elanco. Its innovative approach and promising results position Resilient Biotics as a key player in the analytics and biotechnology industries.

Taxonomy: microbiome-based therapeutics, respiratory infections, genomic analyses, machine learning algorithms, in vitro assays, viral infectious diseases, bacterial infectious diseases, livestock health, antibiotic alternatives, big data analytics, infectious disease prevention, livestock industry, immune activation, pathogen inhibition, veterinary healthcare

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 4
Investor Investor Investor
•••• •••• 		29 Jan 2021

Resilient Biotics Alternatives & Competitors

Resilient Biotics vs
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. United States

Pioneering rational design of drugs made of defined bacteria consortia that are essential dwellers o...

Grant
89 employees
Biotechnology
Compare Resilient Biotics vs Vedanta Biosciences, Inc.
Resilient Biotics vs
Applied BioCode, Inc.
Applied BioCode, Inc. United States

The Ideal Choice for Cost-Effective High Throughput Syndromic Panels

Series Unknown
60 employees
Biotechnology, Health Care
Resilient Biotics vs
Pulmocide
Pulmocide United Kingdom

Developing best-in-class inhaled medicines for targeted treatment of life-threatening respiratory di...

Series C
25 employees
Biotechnology, Health Care
Also compare with: Resilient Biotics vs mCureX Therapeutics, Inc. mCureX Therapeutics, Inc.

FAQ About Resilient Biotics

Harnessing the power of the respiratory microbiome
Resilient Biotics was founded in 2016.
Resilient Biotics is headquartered in Durham, United States.
Resilient Biotics operates in the following industries: Analytics, Biotechnology, Health and Wellness.
Resilient Biotics has approximately 13 employees.
Resilient Biotics has completed 1 funding round, raising a total of $7.17M. The latest funding stage is Series A.
Top alternatives and competitors to Resilient Biotics include Vedanta Biosciences, Inc., Applied BioCode, Inc., Pulmocide, MBF Therapeutics Inc., ILiAD Biotechnologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Resilient Biotics and Vedanta Biosciences, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Resilient Biotics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy